Addressing Delays in Prior Authorization Processes That Negatively Impact PatientsByJohn Barbieri, MD, MBA, FAAD,Kaitlyn Bader, Assistant Managing EditorDecember 12th 2025
Emerging Topical Alternatives to Hydroquinone in Melasma ManagementByMarie Bosslett, Assistant EditorDecember 12th 2025
JAK Inhibitors Show Comparable Safety to TNF AntagonistsByMaddi Hebebrand, MC, Associate EditorDecember 12th 2025